Cite
HARVARD Citation
Li, H. et al. (n.d.). Very Low-Dose Decitabine is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome. Leukemia research. pp. S65-S66. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, H. et al. (n.d.). Very Low-Dose Decitabine is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome. Leukemia research. pp. S65-S66. [Online].